Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.

Bronzina E, Clement A, Marie B, Fook Chong KT, Faure P, Passeron T

Open source

DOI
10.1111/jdv.16150
Published
2020 Apr
Container
Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jdv.16150,
  title = {Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4\% hydroquinone.},
  author = {Bronzina E and Clement A and Marie B and Fook Chong KT and Faure P and Passeron T},
  year = {2020},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.16150},
  url = {https://doi.org/10.1111/jdv.16150}
}

RIS

TY  - JOUR
TI  - Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.
AU  - Bronzina E
AU  - Clement A
AU  - Marie B
AU  - Fook Chong KT
AU  - Faure P
AU  - Passeron T
PY  - 2020
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.16150
UR  - https://doi.org/10.1111/jdv.16150
ER  - 

APA

E, B., A, C., B, M., KT, F. C., P, F., & T, P. (2020). Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.16150

Source records